2006
DOI: 10.1001/archderm.142.10.1368
|View full text |Cite
|
Sign up to set email alerts
|

Leishmania major Cutaneous Leishmaniasis in HIV-Positive Patients Does Not Spread to Extralesional Sites

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 5 publications
0
6
0
Order By: Relevance
“…However, the relationship is not necessarily linear. Among six African HIV-positive patients with cutaneous L. major infection seen in an outpatient clinic in France between 1997 and 2002, five had DCL and none showed parasite dissemination beyond the lesion, despite a high viral load and very low CD4 levels in the peripheral blood (Ͻ10 cells/l) (99). In DCL, where the tendency for a Th2 response is already established, synergy could emerge early with severe negative consequences for the course of leishmaniasis.…”
Section: Cl-hiv Coinfectionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, the relationship is not necessarily linear. Among six African HIV-positive patients with cutaneous L. major infection seen in an outpatient clinic in France between 1997 and 2002, five had DCL and none showed parasite dissemination beyond the lesion, despite a high viral load and very low CD4 levels in the peripheral blood (Ͻ10 cells/l) (99). In DCL, where the tendency for a Th2 response is already established, synergy could emerge early with severe negative consequences for the course of leishmaniasis.…”
Section: Cl-hiv Coinfectionmentioning
confidence: 99%
“…Leishmania major was reported to cause DCL in a child with AIDS (104), in four coinfected patients with CD4 levels below 10/l, with no visceralization and no relapse after successful treatment (99), and in a severely immunocompromised patient in Burkina Faso, who failed to respond to treatment courses of amphotericin B deoxycholate (AMB), sodium stibogluconate, and liposomal AMB (L-AMB) but responded to miltefosine (234). A longitudinal study in the same country reported clinical polymorphism and a variable treatment response for 32 CL-HIV patients followed over a period of 16 months, with some patients presenting with more than one clinical form (173).…”
Section: Cl-hiv Coinfectionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the clinical presentation of cutaneous leishmaniasis is influenced by the infecting species (13,22), on an individual basis, the clinical presentation is not specific enough to allow a reliable species determination (1,7,13,32). Identification of the species can also help predict the risk of dissemination in immunocompromised patients (10,11). Thus, species identification is important to determine the clinical prognosis and to select the most appropriate therapeutic regimen to be administered to each individual.…”
mentioning
confidence: 99%
“…It is now well documented that CL is caused by more than 22 different species of the genus Leishmania ( L ) but their prevalence varies from region to region [3, 4]. Identification of specific L. species is important for the prescription of appropriate therapy [5]. Treatment of CL patients without identification of L. species cause harmful effects to the patients as the attribution of the relative importance of specific L. species in humans are reported [6].…”
Section: Introductionmentioning
confidence: 99%